UAE Oligonucleotide Synthesis Market Size & Outlook
UAE oligonucleotide synthesis market, 2018-2030 (US$M)
Related Markets
UAE oligonucleotide synthesis market highlights
- The UAE oligonucleotide synthesis market generated a revenue of USD 16.2 million in 2024 and is expected to reach USD 29.3 million by 2030.
- The UAE market is expected to grow at a CAGR of 10.4% from 2025 to 2030.
- In terms of segment, services was the largest revenue generating segment in 2024.
- Services is the most lucrative segment segment registering the fastest growth during the forecast period.
Oligonucleotide synthesis market data book summary
| Market revenue in 2024 | USD 16.2 million |
| Market revenue in 2030 | USD 29.3 million |
| Growth rate | 10.4% (CAGR from 2024 to 2030) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oligonucleotides, Equipment/Synthesizer, Reagents, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio |
Other key industry trends
- In terms of revenue, UAE accounted for 0.4% of the global oligonucleotide synthesis market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia oligonucleotide synthesis market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 44.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oligonucleotide Synthesis Market Scope
Oligonucleotide Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE oligonucleotide synthesis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oligonucleotide synthesis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 37.65% in 2024. Horizon Databook has segmented the UAE oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
The United Arab Emirates (UAE) has a rapidly growing healthcare sector fueled by government investments, an increasing population, and rising disposable incomes. As per the International Trade Administration, the 2022 federal budget of UAE allocated a total of USD 17.18 billion for public expenditures, with 7.6% specifically committed to healthcare.
Moreover, there is a growing awareness of the benefits of genetic testing in the UAE, particularly for prenatal screening, cancer diagnosis, and personalized medicine. This awareness is fueling the demand for oligonucleotides used in these tests.
Furthermore, the UAE government is actively promoting the adoption of precision medicine, which tailors medical treatments to an individual’s genetic makeup. This personalized approach relies heavily on oligonucleotides for targeted therapies and diagnostics.
Reasons to subscribe to UAE oligonucleotide synthesis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE oligonucleotide synthesis market databook
-
Our clientele includes a mix of oligonucleotide synthesis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE oligonucleotide synthesis market , including forecasts for subscribers. This country databook contains high-level insights into UAE oligonucleotide synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE oligonucleotide synthesis market size, by segment, 2018-2030 (US$M)
UAE Oligonucleotide Synthesis Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
